HF978
In CommitteeIAA bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.)
Iowa · Session 2025
Status
In Committee
As of Apr 21, 2025
Last Action
Committee report, recommending amendment and passage. S.J. 960.
Official Source
Official Full Bill TextSummary
An Iowa bill governing the production and administration of psilocybin, including penalties, has received a committee recommendation for amendment and passage. Movement toward passage of a psilocybin production and administration framework could establish the first formal regulatory structure for psilocybin businesses and clinical providers in Iowa.
What
An Iowa bill governing the production and administration of psilocybin, including penalties, has received a committee recommendation for amendment and passage.
Who
retailers and patients
Why
Movement toward passage of a psilocybin production and administration framework could establish the first formal regulatory structure for psilocybin businesses and clinical providers in Iowa.
Want to advertise here?
Get your business listed on buyweed.us
Want to advertise here?
Get your business listed on buyweed.us
More Iowa Cannabis Bills
- HSB753A bill for an act regulating hemp and associated products, providing penalties, and including effective date provisions.Introduced
- SSB3145A bill for an act relating to the taxation of cigarettes, tobacco products, vapor products, and consumable hemp products, and making appropriations to the department of health and human services and the department of justice.Introduced
- HF2206A bill for an act relating to the manufacture, delivery, and possession of marijuana, the licensure of retail marijuana, providing fees, including excise taxes, establishing funds, providing penalties, and including effective date provisions.Introduced
- HF383A bill for an act relating to the controlled substance crystalline polymorph psilocybin. (Formerly HF 14.) Vetoed 6-11-25.Vetoed
- SSB1241A bill for an act relating to state government and finances, including by making, modifying, limiting, or reducing appropriations, distributions, or transfers, authorizing expenditure of unappropriated moneys in special funds, providing for properly related matters including crystalline polymorph psilocybin and medical residency and fellowship positions, making corrections, and including effective date and retroactive applicability provisions.(See SF 659.)Introduced
- HF950A bill for an act relating to hemp products and the definition, possession, and allowable forms of medical cannabidiol.(Formerly HF 105.)Introduced
- HSB279A bill for an act providing for the regulation of hemp products, and making penalties applicable.Introduced
- HF620A bill for an act relating to the production of psilocybin and the administration of psilocybin to persons with post-traumatic stress disorder, and providing penalties.(See HF 978.)Introduced
- SSB1177A bill for an act relating to the controlled substance crystalline polymorph psilocybin.Introduced
- HF351A bill for an act removing psilocybin and psilocyn from the list of substances classified as schedule I controlled substances under Iowa's uniform controlled substances Act.Introduced
- SF163A bill for an act relating to the definition of medical cannabidiol.Introduced
- HF105A bill for an act relating to the definition of medical cannabidiol.(See HF 950.)Introduced
LEGISLATIVE DATA PROVIDED BY LEGISCAN · LICENSED UNDER CC BY 4.0 · UPDATED Aug 18, 2026